SEJAL PATEL: Open Payments
NPI 1629739404 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 7 | $237 |
| UCB, Inc. | 2 | $185 |
| Janssen Biotech, Inc. | 2 | $169 |
| GENZYME CORPORATION | 3 | $148 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56 |
| LEO Pharma Inc. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
Products named: Zoryve, Bimzelx, TREMFYA, DUPIXENT, COSENTYX, LIBTAYO, SPEVIGO, ANZUPGO.
Industry payments across FL — which companies pay providers there.
